RP Bio Inc. (KOSDAQ:314140)
5,760.00
+150.00 (2.67%)
At close: May 29, 2026
-1.54% (1Y)
| Market Cap | 46.97B -1.5% |
| Revenue (ttm) | 137.35B +9.5% |
| Net Income | 5.60B +328.6% |
| EPS | 647.53 +328.2% |
| Shares Out | 8.67M |
| PE Ratio | 8.37 |
| Forward PE | n/a |
| Dividend | 50.00 (0.89%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 10,027 |
| Open | 5,750.00 |
| Previous Close | 5,610.00 |
| Day's Range | 5,510.00 - 5,820.00 |
| 52-Week Range | 5,400.00 - 9,130.00 |
| Beta | 0.46 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |